ACCELERATING ACCESS, PRESERVING EQUITY: WAITLIST TIMES AFTER NORMOTHERMIC MACHINE PERFUSION ADOPTION IN LIVER TRANSPLANTATION

Grace Randall:Icahn School of Medicine at Mount Sinai,New York,United States|Hope Lefebvre:Icahn School of Medicine at Mount Sinai,New York,United States|Regina Longley:Icahn School of Medicine at Mount Sinai,New York,United States|Kimberly Feeney:Icahn School of Medicine at Mount Sinai,New York,United States|Cole Brown:Icahn School of Medicine at Mount Sinai,New York,United States|Aritz Irizar:Icahn School of Medicine at Mount Sinai,New York,United States|Thomas Schiano:Icahn School of Medicine at Mount Sinai,New York,United States|Leona Kim-Schluger:Icahn School of Medicine at Mount Sinai,New York,United States|Leonie van Leeuwen:Icahn School of Medicine at Mount Sinai,New York,United States|Sander Florman:Icahn School of Medicine at Mount Sinai,New York,United States|Mohammed Zeeshan Akhtar:Icahn School of Medicine at Mount Sinai,New York,United States

GALLBLADDER- AND LIVER- DUALLY TARGETED URSODEOXYCHOLIC ACID NANOPARTICLES PROTECT THE HEPATOCYTES AGAINST
HEPATIC ISCHEMIA-REPERFUSION INJURY

Nasha Qiu:Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University,Hangzhou,China|Yangla Xie:Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University,Hangzhou,China|Xiao Xu:NHC Key Laboratory of Combined Multi-Organ Transplantation,Hangzhou,China;Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University,Nanjing,China

HIGH MALIGNANT POTENTIAL AND MULTIFOCAL RECURRENCE IN INTRADUCTAL PAPILLARY NEOPLASM OF THE BILE DUCT: SUPPORTING THE ROLE OF LIVER TRANSPLANTATION IN SELECTED PATIENTS

Marina Vila-Tura:Hepato-biliary and liver transplatation Unit,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain|Lluís Secanella:Hepato-biliary and liver transplatation Unit,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain|Alba Cachero:Hepato-biliary and liver transplatation Unit,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain|David Leiva:Radiology,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain|Teresa Serrano:Pathology,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain|Oriana Barrios:Hepato-biliary and liver transplatation Unit,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain|Kristel Mils:Hepato-biliary and liver transplatation Unit,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain|Marta Garcia-Guix:Hepato-biliary and liver transplatation Unit,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain|Emilio Ramos:Hepato-biliary and liver transplatation Unit,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain|Laura Lladó:Hepato-biliary and liver transplatation Unit,Hospital Universitari de Bellvitge,Hospitalet de Llobregat,Spain

TOTAL INTRAVENOUS VERSUS VOLATILE ANAESTHESIA IN LIVING DONOR HEPATECTOMY: A GLOBAL PROSPECTIVE COHORT STUDY FROM THE INTERNATIONAL LIVING DONOR LIVER TRANSPLANT REGISTRY

Toby Lewis:Critical Care ,Oxford University Hospitals ,Oxford,United Kingdom|Dimitri Raptis:2. Organ Transplant Center of Excellence,King Faisal Specialist Hospital and Research Center,Riyadh,Saudi Arabia|Ilya Kantsedikas:Magill Department of Anaesthesia,Chelsea and Westminster Hospital ,London,United Kingdom|Enrico Prosperi:IRCCS Azienda Ospedaliero,Universitaria di Bologna,Bologna,Italy|Meera Raja:Department of Anaesthesia and Intensive Care ,The Royal Free Hospital,London,United Kingdom|Thomas Fernandez:Department of Anaesthesia and Perioperative Medicine,Auckland City Hospital,Auckland,New Zealand|Michael Spiro:Department of Anaesthesia and Intensive Care ,The Royal Free Hospital,London,United Kingdom

HYPOTHERMIC OXYGENATED PERFUSION (HOPE) EXPANDS DONOR ACCEPTANCE CRITERIA WITH OPTIMAL OUTCOMES: A MULTICENTER MATCHED-COHORT STUDY

Luis Secanella:Bellvitge University Hospital,Barcelona,Spain|Luis M Marin:Virgen del Rocío University Hospital,Sevilla,Spain|Irene Aguirrezabalaga:A Coruña University Hospital,A Coruña,Spain|Alberto Pueyo:Puerta de Hierro University Hospital,Majadahonda,Spain|Mireia Caralt:Vall d'Hebron University Hospital,Barcelona,Spain|Diego Lopez:Badajoz University Hospital,Badajoz,Spain|Beatriz Villota:Cruces University Hospital,Bilbao,Spain|Javier Tejero:Rio Hortega University Hospital,Valladolid,Spain|Marina Vila:Bellvitge University Hospital,Barcelona,Spain|Emilio Ramos:Bellvitge University Hospital,Barcelona,Spain|Laura Lladó:Bellvitge University Hospital,Barcelona,Spain

UNMASKING AGGRESSIVE HCC: THE CLINICAL VALUE OF PIVKA-II OVER AFP

Muhammad Osama tariq Butt:GASTROENTEROLOGY,PKLI,LAHORE,Pakistan|Hafsa Sareen Rai:GASTROENTEROLOGY,PKLI,LAHORE,Pakistan|Ahmad Karim Malik:GASTROENTEROLOGY,PKLI,LAHORE,Pakistan|Imran Ali Syed:GASTROENTEROLOGY,PKLI,LAHORE,Pakistan|Usman Iqbal Aujla:GASTROENTEROLOGY,PKLI,LAHORE,Pakistan

CHOICE OF INTRAOPERATIVE ANALGESIA AND DAY 1 POSTOPERATIVE PAIN IN LIVING DONOR HEPATECTOMY: INSIGHTS FROM THE INTERNATIONAL LIVING DONOR LIVER TRANSPLANT REGISTRY

The International Living Donor Liver Transplant Registry Collaborative:Klinik Hirslanden,Zurich,Switzerland

A COMPARISON OF DONOR OUTCOMES IN LIVING DONOR LIVER TRANSPLANTATION FOR ACUTE LIVER FAILURE AGAINST OTHER INDICATIONS: INSIGHTS FROM THE INTERNATIONAL LDLT REGISTRY (LDLTREGISTRY.ORG)

The International Living Donor Liver Transplant Registry Collaborative:Klinik Hirslanden,Zurich,Switzerland

REFINING PROGNOSIS AFTER LIVER TRANSPLANTATION: CONTRIBUTION OF ARTIFICIAL INTELLIGENCE TO PREDICT EARLY GRAFT DYSFUNCTION

Thomas Levi Strauss:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Christophe Desterke:UMR-S 1193,INSERM,Villejuif,France|Astrid Laurent Bellue:Anatomie & Cytologie Pathologique,Hopital Kremlin Bicetre,Kremlin Bicetre,France|Philippe Ichai:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Eric Vibert:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Audrey Coilly:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Ilias Kounis:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France

MEDICATION ADHERENCE AND LIVER TRANSPLANTATION SURVIVAL: A NATIONWIDE COHORT STUDY

Ilias Kounis:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Cyrille Feray:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Bruno Roche:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Thomas Breard:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Antoine Martin:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Isabelle Boytchev:Gastroenterology department,Hopital Kremlin Bicetre,Kremlin Bicetre,France|Eric Vibert:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France|Antoine Meyer *:Gastroenterology department,Hopital Kremlin Bicetre,Kremlin Bicetre,France|Audrey Coilly *:Centre Hepatobiliaire,Hopital Paul Brousse,Villejuif,France